While YAP1 activation is a major bypass mechanism to EGFR and MAPK pathway inhibition, the role of YAP1 as a mechanism of resistance to therapy seems to be general in many cancer types and independent of the type of treatment used. The gene discussed is YAP1; the disease is cancer.